1 / 7

Innovative Virology Research and Development: American Entrepreneur Clark Swanson's Contributions to fighting Covid-19

Clark Swanson, is co-founder of Vilotos Pharmaceuticals, and was an early advocate and pioneer of drug development in the fight against Covid-19. In 2020, with the Covid-19 pandemic, Mr. Swanson applied the concept of using certain flavonoid based cancer drugs into treatment areas of Covid-19. His commitment to developing therapies for Covid-19 and other diseases has the potential to save countless lives and improve the quality of life for millions of people around the world.

johnbernardus6
Download Presentation

Innovative Virology Research and Development: American Entrepreneur Clark Swanson's Contributions to fighting Covid-19

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Innovative Virology Research and Development: American Entrepreneur Clark Swanson's Contributions to fighting Covid-19

  2. Clark Swanson, is co-founder of Vilotos Pharmaceuticals, and was an early advocate and pioneer of drug development in the fight against Covid-19. He maintains an interest in research and development for drugs also used to treat other infectious diseases such as HIV/AIDS, Hepatitis, and other viruses. Vilotos Pharmaceuticals is a virology company based in Baltimore, MD that focuses on research and development to find cures for these diseases. Mr. Swanson is a patent author and co-inventor of the drugs that are being developed.

  3. Mr. Swanson's background in cancer research and drug development was instrumental in the development of the drug platform used by Vilotos Pharmaceuticals to create its virology drug portfolio. Mr. Swanson was an early pioneer in Flavocure Biotech’s cancer research at Harvard Medical School and having placed significant financial resources into the search for a cure to cancer, Swanson facilitated new drug applications and novel therapies.

  4. In 2020, with the Covid-19 pandemic, Mr. Swanson applied the concept of using certain flavonoid based cancer drugs into treatment areas of Covid-19. He recognized the efficacy of flavonoids, such as Quercetin for SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome). While the drugs performed well against certain influenza viruses, they did not reach efficacy against SARS-COV-2 virus.

  5. Mr. Swanson's continues his dedication to finding cures for diseases and this effort is unwavering. Along with a team of PhD's and MD's from prestigious universities such as the University of Maryland, Harvard Medical School, and John's Hopkins, his drug received Orphan Drug designation from the FDA. Meanwhile, the Covid-19 pandemic has highlighted the critical need for new treatments and vaccines to combat infectious diseases.

  6. Mr. Swanson's dedication to finding cures for diseases has not gone unnoticed. His work has earned him recognition and accolades from the medical and scientific communities. His commitment to developing therapies for Covid-19 and other diseases has the potential to save countless lives and improve the quality of life for millions of people around the world. • More information about Clark Swanson can be found at www.clarkswanson.com.

  7. Thank YouClark Swanson

More Related